chemistry
Quantum dots brighten the future of lighting
May. 8, 2012—Vanderbilt researchers have boosted the efficiency of a novel source of white light called quantum dots more than tenfold, making them of potential interest for commercial applications.
Neuronal clues to cholesterol-defect disorder
Apr. 20, 2012—Antioxidants may be a beneficial treatment for an inherited genetic disorder.
Vanderbilt expanding research enterprise into Williamson County
Mar. 9, 2012—With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County.
VU researcher has personal motive for investigating malaria
Feb. 3, 2012—Vanderbilt researcher and Gabon, Africa, native is working to discover ways to kill malaria-spreading mosquitoes.
“Extractionator” could bring high-tech medical diagnostics to rural areas
Dec. 16, 2011—The Bill and Melinda Gates Foundation has given them $1 million to three Vanderbilt scientists to develop a point-of-care sample collection and preparation product that could bring advanced medical diagnostic testing to the third world.
Vanderbilt sets record for number of new AAAS fellows
Dec. 14, 2011—Fourteen Vanderbilt researchers have been elected fellows of the American Association for the Advancement of Science (AAAS).
Pushing lipids into the limelight
Dec. 6, 2011—In the world of molecular biology, lipids haven’t gotten as much respect or attention as nucleic acids and proteins even though they play a number of essential biological functions. But now this chemically diverse class of molecules is emerging into the limelight. The development of new instruments that can efficiently identify fats, waxes, sterols, membrane...
Creation of the largest human-designed protein boosts protein engineering efforts
Nov. 15, 2011—A team of Vanderbilt chemists have designed and successfully synthesized the largest artificial protein using a new approach that greatly expands scientists’ ability to create proteins unknown in nature.
Fungus toxin gets in the way in DNA
Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.
Study puts a new spin on ibuprofen’s actions
Sep. 29, 2011—Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs.
New technique maps twin faces of smallest Janus nanoparticles
Sep. 26, 2011—Vanderbilt chemists have developed the first method that can rapidly and accurately map the surfaces of tiny particles that possess two chemically distinct faces. The findings have broad potential applications ranging from drug delivery to video displays.
Milestone in development of new treatment for ‘fragile X’
Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.